Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients
Author:
Affiliation:
1. Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China; and
2. Department of Hematology, Second Artillery General Hospital, Beijing, China
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/117/3/936/1462365/zh800311000936.pdf
Reference33 articles.
1. Acute myeloid leukemia.;Lowenberg;N Engl J Med,1999
2. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.;Prebet;J Clin Oncol,2009
3. A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients.;Olivieri;Exp Hematol,2007
4. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.;Farag;Blood,2006
5. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.;Mayer;N Engl J Med,1994
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HLA-mismatched micro-transplantation as post-remission treatment compared to autologous hematopoietic stem cell transplantation or consolidation with single agent cytarabine for favorable-or intermediate-risk acute myeloid leukemia;Hematology;2023-07-05
2. Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group;Heliyon;2023-04
3. USP11 plays a critical role in the onset and progression of acute graft-versus-host disease:Novel target for precision therapeutics;Pharmacological Research;2023-03
4. Harnessing allogeneic CD4<sup>+</sup> T cells to reinvigorate host endogenous antitumor immunity;FUKUSHIMA JOURNAL OF MEDICAL SCIENCE;2023
5. Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia;Stem Cells Translational Medicine;2022-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3